Between 2023 and 2033, the laboratory balances and scales market is projected to grow at a 4.3% average CAGR. The market is anticipated to grow from its predicted value of US$ 1.31 billion in 2023 to a market share of US$ 2.0 billion by 2033. •The market expansion is fueled by the increased use of …
Category Archives: Healthcare Trends
Prothrombin Complex Concentrates Market Sets Sail on a US$ 1.2 Billion Odyssey by 2033-FMI Projection
From a predicted US$ 772.0 million in 2023, the prothrombin complex concentrates market sales is expected to reach a valuation of US$ 1.2 billion by 2033. Demand for prothrombin complex concentrate is expected to rise at a steady 4.1% CAGR, with China, India, the US, and the UK emerging as key producers. The global Prothrombin …
Global Surgical Drapes Industry is forecasted to experience a 4.2% CAGR from 2023 to 2033, driven by the increasing need for effective solutions in managing chronic diseases, as per FMI
According to a recently released Future Market Insights study, the global surgical drapes industry size is expected to generate sales of US$ 1.4 billion in 2023 and expand at a CAGR of 4.2% from 2023 to 2033. The market is anticipated to reach US$ 2.1 billion by the end of 2033. From 2023 to 2033, …
Global Complicated Urinary Tract Infections Treatment Industry is on track for growth, projected to experience a 5.76% CAGR by 2033 | FMI
The global complicated urinary tract infections treatment industry demand is expected to surpass an impressive valuation of US$ 9.2 billion in 2023 and is projected to reach US$ 16.1 billion by 2033, trailing a CAGR of 5.76%. An advanced platform called biosensors are used for the diagnosis of complicated urinary tract infection which will drive …
Global Oncology-based In-Vivo CRO Industry is expected to attain US$ 2.9 Billion by 2033, growing consistently at a 10.9% CAGR, according to FMI
The global oncology-based in-vivo CRO industry size is worth US$ 1.1 Billion as of now and is expected to reach US$ 2.9 Billion by the year 2033 at a notable CAGR of 10.9% between 2023 and 2033. The WHO states that as of the year 2020, 19.3 Million novel cases of cancer were reported along …
Global Dengue Fever Treatment Industry is anticipated to touch US$ 5435.25 Million by 2033 at a CAGR of 20% | FMI
The global dengue fever treatment industry size is expected to grow from US$ 877.82 million in 2023 to US$ 5435.25 million by 2033, at a CAGR of 20%. Dengue fever is a mosquito-borne viral infection that causes a flu-like illness. It is one of the most common mosquito-borne diseases in the world, and it is …
Global Cryotherapy Industry will experience a remarkable growth to US$ 14.1 Billion by 2033, propelled by advancements in surgical techniques | Future Market Insights
As per the latest analysis report on the global cryotherapy industry demand by Future Market Insights, the market is poised for significant growth. With a projected compound annual growth rate (CAGR) of 11.2%, the cryotherapy market is expected to reach a valuation of US$ 4.9 billion by the year 2023, and by 2033, it is …
Global Scar Treatment Industry is set to achieve a valuation of US$ 52.2 Billion by 2032 with a CAGR of 13.6%, according to FMI
According to a Future Market Insights analysis report, the global scar treatment industry size is projected to reach US$ 14.6 billion in 2022. The market is anticipated to surpass US$ 52.2 billion by 2032, with a CAGR of 13.6% from 2022 to 2032. The market for hospitals is anticipated to generate the largest revenue and …
Global Biopsy Guidance Systems Industry is set to play a pivotal role in reshaping disease diagnosis techniques, with FMI forecasting a significant US$ 2 Billion by 2032
The global biopsy guidance system industry size is anticipated to create an opulent growth outlook of the market over the assessment period by registering a CAGR of 5.8% from 2022 to 2032. The global market is valued at US$ 458 Million in 2022 and is expected to surpass a valuation of US$ 2 Billion by …
Global Primary Sclerosing Cholangitis (PSC) Industry is estimated to surpass US$ 314.26 Million by 2033, according to FMI
The global primary sclerosing cholangitis (PSC) industry size is expected to be worth US$ 151.07 million in 2023. Because of rising alcohol consumption, the overall demand for Primary Sclerosing Cholangitis (PSC) is expected to grow at a CAGR of 7.6% between 2023 and 2033, totaling around US$ 314.26 Million by 2033. The Primary Sclerosing Cholangitis …